Is 4Sc AG halal to invest in?

According to Musaffa's Shariah screening methodology, 4Sc AG (VSC.F) is currently classified as NOT HALAL as of January 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is 4Sc AG a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes 4Sc AG using these criteria to determine its compliance status.

Can Muslims buy shares of 4Sc AG?

Muslim investors may consider investing in 4Sc AG if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is 4Sc AG classified as NOT HALAL?

Musaffa determines the Shariah status of 4Sc AG by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for 4Sc AG updated?

The Shariah compliance status of 4Sc AG may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like 4Sc AG become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of 4Sc AG?

You can check the latest Shariah compliance status of 4Sc AG on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

4Sc AG VSC.F

€0.10 €0.03 (23.08%) 1D

Last Updated: Dec 16, 12:00 AM·XFRA

VSC.F Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: January 20, 2026

Report Source: 2025 2nd Quarter Report

4Sc AG. Stock Analysis VSC.F

Germany Health Care Nano Cap Report: Q2, 2025

4SC AG is a clinical-stage biopharmaceutical company, which engages in the development of small molecule drugs that target key indications in cancer. The company is headquartered in Planegg, Bayern and currently employs 14 full-time employees. The company went IPO on 2008-02-25. The Company’s product pipeline includes several anti-cancer drugs, which are in various stages of preclinical and clinical development. Its main products are Resminostat, an orally administered histone deacetylase (HDAC) inhibitor for the treatment of a broad spectrum of oncology indications, both in monotherapy in combination with other anti-cancer drugs; 4SC-202, an orally administered small molecule and epigenetic modulator that inhibits the enzymes lysine-specific demethylase 1 (LSD1) and histone deacetylase (HDAC) 1, 2, 3, and 4SC-208, a small molecule that targets two kinases for Hedgehog/GLI signaling.

Key Statistics of 4Sc AG (VSC.F)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€0.09€0.14

Today's Open

€0.13

Volume

55.26K

P/E Ratio (TTM)

52 Week Range

€0.09€3.70

Market Cap

1.09M

Avg. Volume

18.89K

Dividend Yield

Financial Metrics & Statements of 4Sc AG (VSC.F)

FAQ's for 4Sc AG (VSC.F)

According to Musaffa’s Shariah screening methodology, 4Sc AG (VSC.F) is currently classified as NOT HALAL as of January 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.